Moderna, Merck Shares Soar on Cancer Vaccine Trial Success
Investors poured into Moderna and Merck on Wednesday after the two pharmaceutical giants announced a major victory in their fight against skin cancer. A late stage clinical trial revealed that a personalized mRNA vaccine called intismeran, used in tandem with Merck’s immunotherapy drug Keytruda, significantly prevented melanoma from returning in high risk patients. The results […]
